🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Julie M. Shabto

Hara Eye Hospital

ORCID: 0000-0003-0991-9294
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors”.

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851
N/A
0.515DataRank · unranked
30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563
N/A
0.104DataRank · unranked
1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738
N/A
0.104DataRank · unranked
1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393
N/A
0DataRank · unranked
4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932
N/A
0DataRank · unranked
18 citations

Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, Emilie Elise Hitron +11 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154
N/A
0DataRank · unranked
12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.734
N/A
0DataRank · unranked
1 citations

Dylan J. Martini, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Elise Hitron +8 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922
N/A
0DataRank · unranked
32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more